Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
4.17
Oct 22 • 10:44 AM ET Dollar change+0.12 Percentage change(2.96%)
Index
-
Market Cap
78.29M
Enterprise Value
35.55M
Income
-74.29M
Sales
117.80M
Book/sh
5.13
Cash/sh
7.84
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
310
IPO
Sep 15, 2020
P/E
-
Forward P/E
-
PEG
-
P/S
0.66
P/B
0.81
P/C
0.53
P/FCF
-
EV/EBITDA
-
EV/Sales
0.30
Quick Ratio
4.11
Current Ratio
5.19
Debt/Eq
1.08
LT Debt/Eq
1.06
Option/Short
Yes / Yes
EPS (ttm)
-4.10
EPS next Y
-2.29
EPS next Q
-0.69
EPS this Y
28.29%
EPS next Y
25.62%
EPS next 5Y
24.51%
EPS past 3/5Y
52.71% 28.06%
Sales past 3/5Y
1.17% 19.06%
EPS Y/Y TTM
79.82%
Sales Y/Y TTM
-1.26%
EPS Q/Q
7.57%
Sales Q/Q
0.69%
Insider Own
5.90%
Insider Trans
23.25%
Inst Own
75.20%
Inst Trans
-9.93%
ROA
-27.97%
ROE
-59.17%
ROIC
-37.48%
Gross Margin
41.76%
Oper. Margin
-55.82%
Profit Margin
-63.06%
SMA20
9.01%
SMA50
11.27%
SMA200
-0.11%
Trades
Shs Outstand
18.80M
Shs Float
17.69M
52W High
15.94 -73.84%
52W Low
2.84 46.81%
Volatility
10.45% 8.64%
ATR (14)
0.29
RSI (14)
58.29
Beta
2.00
Rel Volume
0.14
Avg Volume
155.43K
Volume
4,916
Perf Week
2.21%
Perf Month
34.95%
Perf Quarter
3.22%
Perf Half Y
-8.75%
Perf YTD
12.40%
Perf Year
-72.29%
Perf 3Y
-92.43%
Perf 5Y
-99.46%
Perf 10Y
-
Prev Close
4.05
Price
4.17
Change %
2.96%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leonard Braden Michael10% OwnerOct 01 '26Buy3.53228,334806,0192,748,035Oct 05 07:24 PM
Leonard Braden Michael10% OwnerOct 02 '26Buy3.8816,57564,2412,764,610Oct 05 07:24 PM
Trigg LeslieChair and CEOAug 17 '26Sale4.393,43715,088194,597Aug 18 07:45 PM
Brottem John L.General CounselAug 17 '26Sale4.392,63211,55487,475Aug 18 06:51 PM
Gaeta ReneeChief Financial OfficerAug 17 '26Sale4.394,54319,944180,840Aug 18 06:46 PM
Trigg LeslieOfficerAug 17 '26Proposed Sale4.513,34415,080Aug 14 09:20 PM
Brottem John L.OfficerAug 17 '26Proposed Sale4.512,56211,549Aug 14 09:19 PM
Gaeta ReneeOfficerAug 17 '26Proposed Sale4.514,42219,939Aug 14 09:16 PM
Gaeta ReneeChief Financial OfficerJun 03 '26Sale4.9417,67287,300113,753Jun 05 06:07 PM
Gaeta ReneeOfficerJun 03 '26Proposed Sale4.9417,67287,385Jun 03 07:35 PM
Trigg LeslieChair and CEOMay 15 '26Sale3.703,44512,74698,874May 19 09:08 PM
Nash MarcEVP Operations R&D & ServiceMay 15 '26Sale3.701,5825,85338,393May 19 09:08 PM
Brottem John L.General CounselMay 15 '26Sale3.702,6389,76130,277May 19 09:08 PM
Brottem John L.OfficerMay 15 '26Proposed Sale3.702,6389,761May 15 09:48 PM
Nash MarcOfficerMay 15 '26Proposed Sale3.701,5825,853May 15 09:48 PM
Trigg LeslieOfficerMay 15 '26Proposed Sale3.703,44512,746May 15 09:46 PM
Brottem John L.General CounselFeb 17 '26Sale3.352,8429,52132,935Feb 19 08:57 PM
Trigg LeslieChair and CEOFeb 17 '26Sale3.353,36111,259102,342Feb 19 08:57 PM
Nash MarcEVP Operations R&D & ServiceFeb 17 '26Sale3.351,8176,08739,988Feb 19 08:56 PM
Trigg LeslieOfficerFeb 17 '26Proposed Sale3.353,36111,259Feb 17 09:16 PM
Brottem John L.OfficerFeb 17 '26Proposed Sale3.352,8429,521Feb 17 09:13 PM
Nash MarcEVP Operations R&D & ServiceJan 20 '26Sale5.125,37527,52042,785Jan 21 07:07 PM
Nash MarcEVP Operations R&D & ServiceJan 21 '26Sale4.989804,88041,805Jan 21 07:07 PM
Brottem John L.General CounselJan 20 '26Sale5.129,31447,68836,957Jan 21 07:05 PM
Brottem John L.General CounselJan 21 '26Sale5.011,1805,91235,777Jan 21 07:05 PM
Trigg LeslieChair and CEOJan 20 '26Sale5.1211,79460,385107,823Jan 21 06:54 PM
Trigg LeslieChair and CEOJan 21 '26Sale5.052,12010,706105,703Jan 21 06:54 PM
Trigg LeslieOfficerJan 21 '26Proposed Sale5.052,12010,697Jan 21 06:29 PM
Nash MarcOfficerJan 21 '26Proposed Sale4.989804,876Jan 21 06:26 PM
Brottem John L.OfficerJan 21 '26Proposed Sale5.011,1805,914Jan 21 06:25 PM
Nash MarcOfficerJan 20 '26Proposed Sale5.125,37527,520Jan 20 08:13 PM
Trigg LeslieOfficerJan 20 '26Proposed Sale5.1211,79460,385Jan 20 08:12 PM
Brottem John L.OfficerJan 20 '26Proposed Sale5.129,31447,683Jan 20 08:11 PM
Nash MarcEVP Operations R&D & ServiceJan 07 '26Sale4.2710846148,160Jan 08 05:10 PM
Brottem John L.General CounselJan 07 '26Sale4.2722495646,271Jan 08 05:09 PM
Trigg LeslieChair and CEOJan 07 '26Sale4.271,7957,665119,617Jan 08 05:05 PM
Nash MarcOfficerJan 07 '26Proposed Sale4.27108461Jan 07 06:09 PM
Trigg LeslieOfficerJan 07 '26Proposed Sale4.271,7957,665Jan 07 06:07 PM
Brottem John L.OfficerJan 07 '26Proposed Sale4.27224956Jan 07 06:05 PM
Drexler KarenDirectorDec 01 '25Sale4.371,5486,76510,650Dec 02 05:39 PM
Trigg LeslieChair and CEONov 17 '25Sale4.609164,214121,412Nov 18 04:37 PM
Nash MarcEVP Operations R&D & ServiceNov 17 '25Sale4.602471,13648,268Nov 18 04:33 PM
Brottem John L.General CounselNov 17 '25Sale4.603881,78546,495Nov 18 04:28 PM
Nash MarcOfficerNov 17 '25Proposed Sale4.602471,136Nov 17 06:48 PM
Trigg LeslieOfficerNov 17 '25Proposed Sale4.609164,214Nov 17 06:45 PM
Brottem John L.OfficerNov 17 '25Proposed Sale4.603881,785Nov 17 06:43 PM
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
PresidentMs. Leslie L. Trigg
CFOMs. Renee M. Gaeta